• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Introduction to 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic Acid (CAS No. 1261949-13-6)

2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, identified by its Chemical Abstracts Service (CAS) number 1261949-13-6, is a derivative of benzoic acid, featuring a fluoro and methyl substitution pattern on its aromatic ring system. The structural configuration of this molecule imparts unique electronic and steric properties, making it a valuable scaffold for the development of novel bioactive agents.

The presence of a fluorine atom at the 3-position and a methyl group at the 4-position of the phenyl ring enhances the lipophilicity and metabolic stability of the compound. These modifications are strategically important in medicinal chemistry, as they can influence binding affinity, pharmacokinetic profiles, and overall biological activity. The 5-methylbenzoic acid moiety further contributes to the molecular framework, providing a basis for further functionalization and derivatization.

Recent advancements in computational chemistry and molecular modeling have highlighted the potential of 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid as a lead compound for drug discovery. Its structural features align well with the pharmacophoric requirements of several therapeutic targets, including enzymes and receptors involved in inflammatory responses, metabolic disorders, and neurodegenerative diseases. Studies have demonstrated that such fluorinated aromatic compounds exhibit enhanced binding interactions due to the electron-withdrawing nature of fluorine, which can improve receptor affinity and selectivity.

In the context of modern drug development, 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid has been explored as a precursor for synthesizing more complex derivatives with tailored biological activities. For instance, researchers have investigated its potential as an intermediate in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants. The fluoro-substituted aromatic ring is particularly noteworthy, as fluorine atoms are known to modulate drug efficacy by influencing electronic distribution and metabolic resistance.

The compound's relevance is further underscored by its application in high-throughput screening (HTS) campaigns aimed at identifying novel therapeutic candidates. Its molecular structure allows for rapid optimization through structure-activity relationship (SAR) studies, enabling researchers to fine-tune its properties for specific biological endpoints. Additionally, the methyl groups at the 4- and 5-positions contribute to steric hindrance, which can be leveraged to improve binding specificity and reduce off-target effects.

Emerging research also suggests that 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid may have applications beyond traditional pharmaceuticals. For example, its derivatives have shown promise in materials science, particularly in the development of organic semiconductors and liquid crystals due to their aromatic backbone and functionalizable side chains. This interdisciplinary potential highlights the versatility of such compounds in addressing challenges across multiple scientific domains.

The synthesis of 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid typically involves multi-step organic reactions, including Friedel-Crafts alkylation, fluorination protocols, and carboxylic acid functionalization. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions, have been employed to enhance yield and purity. These synthetic strategies are critical for producing sufficient quantities of the compound for preclinical studies and industrial applications.

From a regulatory perspective, 2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid (CAS No. 1261949-13-6) is subject to standard guidelines governing chemical substances used in research and development. Ensuring compliance with safety protocols and documentation requirements is essential for its handling and distribution. Collaborative efforts between academic institutions and pharmaceutical companies have facilitated standardized protocols for its production and characterization.

The future prospects of this compound are promising, with ongoing investigations exploring its role in next-generation therapeutics. Innovations in synthetic biology and biocatalysis may further streamline its production processes, making it more accessible for large-scale applications. Additionally, advancements in drug delivery systems could enhance the bioavailability and targeted action of derivatives based on this scaffold.

In summary,2-(3-fluoro-4-methylphenyl)-5-methylbenzoic acid represents a significant advancement in medicinal chemistry due to its unique structural features and versatile applications. Its contributions to drug discovery, material science, and interdisciplinary research underscore its importance as a building block for innovative solutions across scientific disciplines.

• 1024-95-9(2-(2-fluoro-4-methylphenyl)-5-methylbenzoic Acid)
• 139911-15-2([1,1'-Biphenyl]-2-carboxylic acid, 4,4'-difluoro-3'-methyl-)
• 1179643-93-6(4-fluoro-2-(4-fluoro-3-methylphenyl)benzoic acid)
• 1261973-20-9(3-(2,5-Difluorophenyl)-2-methylbenzoic acid)
• 1261940-97-9(2-(3-Fluoro-4-methylphenyl)benzoic acid)
• 1261940-93-5(2-(3-fluoro-2-methylphenyl)benzoic Acid)
• 1261903-17-6(2-(3-fluoro-2-methylphenyl)-6-methylbenzoic Acid)
• 1261939-28-9(2-(2-fluoro-4-methylphenyl)-6-methylbenzoic Acid)
• 1261929-13-8(3-(2-carboxy-4-fluorophenyl)-4-fluorobenzoic Acid)
• 1261927-08-5(3-(2-carboxy-5-fluorophenyl)-4-fluorobenzoic Acid)